GPR85 and central nervous system cancer: Here, we found that they were more like a group of grade II and grade IV like gliomas based on the expression of three genes: GPR85, SHOX2 and HMBOX1. The two groups showed distinct clinical, molecular features and prognosis, which were extremely similar to that of grade II and grade IV gliomas, respectively.